Ablation AFIB Innovation 
DAIC
JUNE 11, 2024
Innovation in medical technology exists to improve patient outcomes, increase surgical efficiency and enhance patient safety. Infrequently, we see medical technology innovation of a paradigmatic nature that changes the way physicians approach disease states and dramatically improve results.
DAIC
JANUARY 18, 2024
milla1cf Thu, 01/18/2024 - 14:21 January 18, 2024 — Abbott announced the first global procedures have been conducted using the company's new Volt Pulsed Field Ablation (PFA) System to treat patients battling common abnormal heart rhythms such as atrial fibrillation (AFib).
DAIC
FEBRUARY 2, 2024
Titled "Real-world Data Affirms Safety and Effectiveness of Low/Zero Fluoroscopy Atrial Fibrillation Ablation," the study was presented as a late-breaker at the 29th Annual International AF Symposium. Biosense Webster's zero fluoroscopy workflow is the first and only such workflow available in a radiofrequency (RF) cardiac ablation device.
ADN Center of Excellence
SEPTEMBER 2, 2024
September is National Atrial Fibrillation (AFib) Awareness Month, a time dedicated to raising awareness about one of the most common yet often misunderstood heart conditions. Physicians have a crucial role in recognizing, diagnosing, and managing AFib to prevent its potentially life-threatening complications.
ADN Center of Excellence
SEPTEMBER 2, 2024
September is National Atrial Fibrillation (AFib) Awareness Month, a time dedicated to raising awareness about one of the most common yet often misunderstood heart conditions. Physicians have a crucial role in recognizing, diagnosing, and managing AFib to prevent its potentially life-threatening complications.
DAIC
DECEMBER 22, 2023
Additionally, this platform integrates parameters such as contact force measurement and ablation indexes for RF and PFA which have proven in preclinical studies to be critical for lesion creation. With this differentiated system, Biosense Webster is giving EPs the tools and information they need in real-time.
CardiacWire
DECEMBER 13, 2023
In August, J&J’s Biosense Webster announced that six of its AFib ablation products (e.g. The company also brought on medtech robotics veteran Pablo Garcia as its new GM, who previously co-founded Verb Surgical, which became the foundation of J&J’s forthcoming Ottava robotics surgery platform.
Expert insights. Personalized for you.
104 
Let's personalize your content